Olanzapine: a novel atypical neuroleptic agent
- 1 May 1997
- journal article
- Published by Elsevier in The Lancet
- Vol. 349 (9061) , 1264-1265
- https://doi.org/10.1016/s0140-6736(97)22018-0
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trialAmerican Journal of Psychiatry, 1997
- A PET Study of 5-HT2 and D2 Dopamine Receptor Occupancy Induced by Olanzapine in Healthy SubjectsNeuropsychopharmacology, 1997
- Olanzapine: A New Atypical Antipsychotic DrugNeuropsychopharmacology, 1996
- Olanzapine versus Placebo and HaloperidolNeuropsychopharmacology, 1996
- Electrophysiological Effects of Olanzapine, a Novel Atypical Antipsychotic, on A9 and A10 Dopamine NeuronsNeuropsychopharmacology, 1996
- Radioreceptor Binding Profile of the Atypical Antipsychotic OlanzapineNeuropsychopharmacology, 1996
- Effects of Olanzapine on Regional C-Fos Expression in Rat ForebrainNeuropsychopharmacology, 1996
- The role of 5-HT2A receptors in antipsychotic activityLife Sciences, 1995